

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 7.00950482 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.81700567 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.19056898 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.19056898 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.19056898 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.19056898 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.19056898 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 6.19056898 |
| 9 | respiratory burst (GO:0045730) | 6.02930328 |
| 10 | leukocyte aggregation (GO:0070486) | 5.49016880 |
| 11 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.32887510 |
| 12 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.16103195 |
| 13 | neutrophil mediated immunity (GO:0002446) | 5.14295303 |
| 14 | reactive oxygen species biosynthetic process (GO:1903409) | 5.03899661 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.01208263 |
| 16 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.90639847 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.83007503 |
| 18 | granulocyte activation (GO:0036230) | 4.80825001 |
| 19 | neutrophil activation (GO:0042119) | 4.77984594 |
| 20 | superoxide anion generation (GO:0042554) | 4.72900075 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.69613127 |
| 22 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.66071475 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.61571688 |
| 24 | response to host immune response (GO:0052572) | 4.61571688 |
| 25 | monocyte chemotaxis (GO:0002548) | 4.51437426 |
| 26 | regulation of macrophage chemotaxis (GO:0010758) | 4.50112083 |
| 27 | eosinophil chemotaxis (GO:0048245) | 4.39239977 |
| 28 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.38545576 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 4.35312527 |
| 30 | response to fungus (GO:0009620) | 4.32251169 |
| 31 | cellular extravasation (GO:0045123) | 4.31514433 |
| 32 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.30623232 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.24851028 |
| 34 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.19356984 |
| 35 | positive regulation of mast cell degranulation (GO:0043306) | 4.19356984 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 4.16742998 |
| 37 | regulation of vitamin metabolic process (GO:0030656) | 4.16736280 |
| 38 | microglial cell activation (GO:0001774) | 4.16353811 |
| 39 | negative regulation of growth of symbiont in host (GO:0044130) | 4.15908287 |
| 40 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.15908287 |
| 41 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.15908287 |
| 42 | regulation of growth of symbiont in host (GO:0044126) | 4.15908287 |
| 43 | positive regulation of heat generation (GO:0031652) | 4.15425062 |
| 44 | glycosphingolipid catabolic process (GO:0046479) | 4.12547953 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.10901383 |
| 46 | response to host (GO:0075136) | 4.10901383 |
| 47 | response to host defenses (GO:0052200) | 4.10901383 |
| 48 | regulation of mast cell activation (GO:0033003) | 4.07140509 |
| 49 | regulation of podosome assembly (GO:0071801) | 4.05558000 |
| 50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.04606354 |
| 51 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.03304787 |
| 52 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.03304787 |
| 53 | eosinophil migration (GO:0072677) | 4.03054406 |
| 54 | leukocyte mediated cytotoxicity (GO:0001909) | 3.96592815 |
| 55 | regulation of fever generation (GO:0031620) | 3.95270977 |
| 56 | positive regulation of interferon-alpha production (GO:0032727) | 3.94802812 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.92633608 |
| 58 | neutrophil chemotaxis (GO:0030593) | 3.90562118 |
| 59 | myeloid leukocyte mediated immunity (GO:0002444) | 3.89132151 |
| 60 | cellular response to cadmium ion (GO:0071276) | 3.88501424 |
| 61 | neutrophil migration (GO:1990266) | 3.79907041 |
| 62 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.76120982 |
| 63 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75953616 |
| 64 | regulation of interferon-alpha production (GO:0032647) | 3.73846307 |
| 65 | oligosaccharide catabolic process (GO:0009313) | 3.72900292 |
| 66 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.71719739 |
| 67 | sequestering of metal ion (GO:0051238) | 3.71336931 |
| 68 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.69973424 |
| 69 | cellular response to zinc ion (GO:0071294) | 3.69652645 |
| 70 | glycolipid catabolic process (GO:0019377) | 3.69300561 |
| 71 | macrophage activation (GO:0042116) | 3.58841263 |
| 72 | regulation of chemokine biosynthetic process (GO:0045073) | 3.58123934 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.57796764 |
| 74 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.55474119 |
| 75 | defense response to fungus (GO:0050832) | 3.54373302 |
| 76 | regulation of leukocyte degranulation (GO:0043300) | 3.54311259 |
| 77 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.54130807 |
| 78 | phagosome maturation (GO:0090382) | 3.53916111 |
| 79 | response to muramyl dipeptide (GO:0032495) | 3.53002631 |
| 80 | cellular response to ethanol (GO:0071361) | 3.50217181 |
| 81 | B cell mediated immunity (GO:0019724) | 3.48142251 |
| 82 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.47291796 |
| 83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.41922067 |
| 84 | granulocyte chemotaxis (GO:0071621) | 3.41134392 |
| 85 | macrophage differentiation (GO:0030225) | 3.41021717 |
| 86 | negative regulation of mast cell activation (GO:0033004) | 3.40305750 |
| 87 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.39934008 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 3.39700021 |
| 89 | response to thyroid hormone (GO:0097066) | 3.37039623 |
| 90 | positive regulation of leukocyte degranulation (GO:0043302) | 3.34161101 |
| 91 | granulocyte migration (GO:0097530) | 3.33333858 |
| 92 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.32171098 |
| 93 | leukotriene metabolic process (GO:0006691) | 3.31662792 |
| 94 | leukocyte degranulation (GO:0043299) | 3.30348405 |
| 95 | detection of other organism (GO:0098543) | 3.28222676 |
| 96 | ceramide catabolic process (GO:0046514) | 3.27807175 |
| 97 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.27750581 |
| 98 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.25596922 |
| 99 | natural killer cell mediated immunity (GO:0002228) | 3.25596922 |
| 100 | barbed-end actin filament capping (GO:0051016) | 3.24395750 |
| 101 | NIK/NF-kappaB signaling (GO:0038061) | 3.23175473 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 3.20175274 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.18155337 |
| 104 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.17961626 |
| 105 | negative regulation of interleukin-17 production (GO:0032700) | 3.16240366 |
| 106 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.15589021 |
| 107 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.12611046 |
| 108 | myeloid leukocyte activation (GO:0002274) | 3.12011270 |
| 109 | regulation of heat generation (GO:0031650) | 3.11716407 |
| 110 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.09946436 |
| 111 | cellular response to lipopolysaccharide (GO:0071222) | 3.09264469 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.08887528 |
| 113 | T-helper 1 type immune response (GO:0042088) | 3.08108402 |
| 114 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.07875411 |
| 115 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.06908397 |
| 116 | amino sugar catabolic process (GO:0046348) | 3.04596926 |
| 117 | membrane lipid catabolic process (GO:0046466) | 3.04139075 |
| 118 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.03872440 |
| 119 | negative regulation of cell killing (GO:0031342) | 3.03872440 |
| 120 | regulation of mononuclear cell migration (GO:0071675) | 3.03667672 |
| 121 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03654667 |
| 122 | cellular response to molecule of bacterial origin (GO:0071219) | 3.02958292 |
| 123 | positive regulation of interferon-beta production (GO:0032728) | 3.02387378 |
| 124 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.00716019 |
| 125 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.00527029 |
| 126 | cell killing (GO:0001906) | 3.00446007 |
| 127 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.99550214 |
| 128 | mast cell activation (GO:0045576) | 2.99536813 |
| 129 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.97896144 |
| 130 | lymphocyte chemotaxis (GO:0048247) | 2.97567680 |
| 131 | germinal center formation (GO:0002467) | 2.96972201 |
| 132 | leukocyte cell-cell adhesion (GO:0007159) | 2.95230056 |
| 133 | killing of cells of other organism (GO:0031640) | 2.93083679 |
| 134 | disruption of cells of other organism (GO:0044364) | 2.93083679 |
| 135 | regulation of lymphocyte migration (GO:2000401) | 2.91360112 |
| 136 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.90010891 |
| 137 | regulation of regulated secretory pathway (GO:1903305) | 2.89448232 |
| 138 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.89297708 |
| 139 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.87784247 |
| 140 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.87334921 |
| 141 | myeloid dendritic cell differentiation (GO:0043011) | 2.87058987 |
| 142 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.86619310 |
| 143 | positive regulation of interleukin-6 production (GO:0032755) | 2.86273165 |
| 144 | detection of external biotic stimulus (GO:0098581) | 2.86270874 |
| 145 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.86228065 |
| 146 | decidualization (GO:0046697) | 2.84887934 |
| 147 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.80219092 |
| 148 | positive regulation of acute inflammatory response (GO:0002675) | 2.79145932 |
| 149 | N-acetylneuraminate metabolic process (GO:0006054) | 2.78225448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.72879124 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.89752353 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.52331906 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.55030112 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.39396351 |
| 6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.08944839 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.04063083 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.90017683 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.63570152 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.54103042 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.40108720 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.06356693 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.99105285 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92396204 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.90904314 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90856382 |
| 17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.78427467 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.73003366 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.72905418 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65072626 |
| 21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.54665577 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38557540 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29855420 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.12058293 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07915077 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06413455 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97808136 |
| 28 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.93636692 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91907509 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.91397851 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88796568 |
| 32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.82786242 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82713388 |
| 34 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.80379020 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79312044 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76386228 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.75989280 |
| 38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72363371 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71211201 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67148278 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.66135994 |
| 42 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56253223 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54980165 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53994638 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.51150925 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50747877 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49517502 |
| 48 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.48781001 |
| 49 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48530891 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48328253 |
| 51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46650156 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46386783 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46334033 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.36120055 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32272633 |
| 56 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29725445 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29324167 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29322240 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29287584 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25223328 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19611980 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19452113 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16907654 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15653980 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13389210 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11266519 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11076319 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08038308 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07047919 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05418037 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98499187 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97496968 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96607210 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95761526 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95470025 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94100189 |
| 77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92902796 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92158326 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92058013 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.91708459 |
| 81 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91569570 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90458043 |
| 83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88774238 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88086994 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88015947 |
| 86 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86911106 |
| 87 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85024724 |
| 88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82812401 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82759018 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81725503 |
| 91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78490367 |
| 92 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77989951 |
| 93 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77570894 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77357119 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76854175 |
| 96 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76681801 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76668204 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76336037 |
| 99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76279030 |
| 100 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74848486 |
| 101 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.74568635 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74504965 |
| 103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73273563 |
| 104 | MAF_26560356_Chip-Seq_TH2_Human | 0.72994465 |
| 105 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.72590952 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68893951 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67676944 |
| 108 | MYC_22102868_ChIP-Seq_BL_Human | 0.67336247 |
| 109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.66104563 |
| 110 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.65906944 |
| 111 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.64155486 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61402563 |
| 113 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.59298116 |
| 114 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.56767134 |
| 115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.55945726 |
| 116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.55339117 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55080909 |
| 118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54939258 |
| 119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.53265426 |
| 120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53133610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003436_decreased_susceptibility_to | 4.22293530 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.20510773 |
| 3 | MP0009785_altered_susceptibility_to | 4.06319456 |
| 4 | MP0003303_peritoneal_inflammation | 4.00807508 |
| 5 | MP0002419_abnormal_innate_immunity | 3.81901013 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.58430664 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.13138206 |
| 8 | MP0005025_abnormal_response_to | 3.10156678 |
| 9 | MP0006082_CNS_inflammation | 2.99754546 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.98437697 |
| 11 | MP0003724_increased_susceptibility_to | 2.83786560 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.65786474 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.65781517 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.52496541 |
| 15 | MP0002723_abnormal_immune_serum | 2.41190053 |
| 16 | MP0001800_abnormal_humoral_immune | 2.35090817 |
| 17 | MP0000343_altered_response_to | 2.32555350 |
| 18 | MP0005671_abnormal_response_to | 2.32167450 |
| 19 | MP0001819_abnormal_immune_cell | 2.30871355 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.29872689 |
| 21 | MP0005387_immune_system_phenotype | 2.28382622 |
| 22 | MP0001790_abnormal_immune_system | 2.28382622 |
| 23 | * MP0001533_abnormal_skeleton_physiology | 2.28341539 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 2.19771454 |
| 25 | MP0009278_abnormal_bone_marrow | 2.10650259 |
| 26 | MP0002405_respiratory_system_inflammati | 2.05613619 |
| 27 | MP0001845_abnormal_inflammatory_respons | 2.05335213 |
| 28 | MP0001853_heart_inflammation | 2.03157086 |
| 29 | MP0003183_abnormal_peptide_metabolism | 2.01650180 |
| 30 | MP0000685_abnormal_immune_system | 2.00281032 |
| 31 | MP0003075_altered_response_to | 1.93883014 |
| 32 | MP0009764_decreased_sensitivity_to | 1.92483916 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.87176589 |
| 34 | MP0003448_altered_tumor_morphology | 1.84694335 |
| 35 | MP0000858_altered_metastatic_potential | 1.77862436 |
| 36 | MP0008469_abnormal_protein_level | 1.67443334 |
| 37 | MP0004510_myositis | 1.67343401 |
| 38 | MP0002006_tumorigenesis | 1.64999416 |
| 39 | MP0004947_skin_inflammation | 1.64089622 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.59901586 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.59766665 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.59766665 |
| 43 | MP0000716_abnormal_immune_system | 1.59591168 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.58030304 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.57303550 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.53156149 |
| 47 | MP0005451_abnormal_body_composition | 1.49377902 |
| 48 | MP0002398_abnormal_bone_marrow | 1.48822595 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.46572917 |
| 50 | MP0005166_decreased_susceptibility_to | 1.41239122 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.40566642 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.39489739 |
| 53 | MP0001851_eye_inflammation | 1.33507659 |
| 54 | MP0003828_pulmonary_edema | 1.32969973 |
| 55 | MP0005310_abnormal_salivary_gland | 1.31675528 |
| 56 | MP0002429_abnormal_blood_cell | 1.31443364 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.29260349 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.28879258 |
| 59 | MP0005164_abnormal_response_to | 1.27104722 |
| 60 | MP0000604_amyloidosis | 1.27020709 |
| 61 | MP0002254_reproductive_system_inflammat | 1.26148183 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.26069820 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.23096213 |
| 64 | MP0003690_abnormal_glial_cell | 1.21268533 |
| 65 | MP0002722_abnormal_immune_system | 1.18635855 |
| 66 | MP0003186_abnormal_redox_activity | 1.17875141 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.14247742 |
| 68 | MP0010307_abnormal_tumor_latency | 1.13627311 |
| 69 | MP0003329_amyloid_beta_deposits | 1.12074787 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.05600248 |
| 71 | MP0002396_abnormal_hematopoietic_system | 1.05463948 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.04645147 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.04159259 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 1.00881653 |
| 75 | MP0009763_increased_sensitivity_to | 1.00739199 |
| 76 | MP0004883_abnormal_blood_vessel | 1.00108254 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.99132521 |
| 78 | * MP0005390_skeleton_phenotype | 0.98809036 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.98111242 |
| 80 | MP0002933_joint_inflammation | 0.97765008 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.97550423 |
| 82 | MP0000490_abnormal_crypts_of | 0.91984095 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.91375571 |
| 84 | MP0009840_abnormal_foam_cell | 0.88827276 |
| 85 | MP0000249_abnormal_blood_vessel | 0.84302260 |
| 86 | MP0004233_abnormal_muscle_weight | 0.84019526 |
| 87 | MP0001849_ear_inflammation | 0.80221148 |
| 88 | MP0008874_decreased_physiological_sensi | 0.79836554 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.79023979 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.77798803 |
| 91 | MP0003091_abnormal_cell_migration | 0.76587421 |
| 92 | MP0003795_abnormal_bone_structure | 0.74850650 |
| 93 | MP0000920_abnormal_myelination | 0.74772107 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.74753924 |
| 95 | MP0008873_increased_physiological_sensi | 0.74568509 |
| 96 | MP0003195_calcinosis | 0.72888453 |
| 97 | MP0005023_abnormal_wound_healing | 0.70576164 |
| 98 | MP0006054_spinal_hemorrhage | 0.69317756 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.68704328 |
| 100 | MP0003634_abnormal_glial_cell | 0.67345382 |
| 101 | MP0008260_abnormal_autophagy | 0.65312382 |
| 102 | MP0001663_abnormal_digestive_system | 0.65134649 |
| 103 | MP0002090_abnormal_vision | 0.63056418 |
| 104 | MP0005647_abnormal_sex_gland | 0.62257995 |
| 105 | MP0003866_abnormal_defecation | 0.60394575 |
| 106 | MP0000371_diluted_coat_color | 0.59587694 |
| 107 | MP0003633_abnormal_nervous_system | 0.57623262 |
| 108 | MP0002019_abnormal_tumor_incidence | 0.57057179 |
| 109 | MP0003763_abnormal_thymus_physiology | 0.57036502 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.56980839 |
| 111 | MP0001958_emphysema | 0.56262900 |
| 112 | MP0000750_abnormal_muscle_regeneration | 0.56260923 |
| 113 | MP0002896_abnormal_bone_mineralization | 0.55248054 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.55244149 |
| 115 | MP0001542_abnormal_bone_strength | 0.54899656 |
| 116 | MP0000703_abnormal_thymus_morphology | 0.53964700 |
| 117 | MP0001873_stomach_inflammation | 0.51739716 |
| 118 | MP0008004_abnormal_stomach_pH | 0.50528262 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.50399335 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.47956530 |
| 121 | MP0005165_increased_susceptibility_to | 0.46064161 |
| 122 | MP0003279_aneurysm | 0.45015249 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.44929312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 9.06710624 |
| 2 | Eczematoid dermatitis (HP:0000976) | 8.26126723 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 8.05277662 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.44004244 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.59424705 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.41206794 |
| 7 | Obstructive lung disease (HP:0006536) | 5.23950481 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 5.23950481 |
| 9 | Gingivitis (HP:0000230) | 4.97690416 |
| 10 | Recurrent skin infections (HP:0001581) | 4.68313050 |
| 11 | Stomatitis (HP:0010280) | 4.57871795 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.42892884 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 4.32867289 |
| 14 | Loss of speech (HP:0002371) | 4.20413845 |
| 15 | Mutism (HP:0002300) | 4.10833061 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 4.03991636 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.99210525 |
| 18 | Myositis (HP:0100614) | 3.96620465 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.89132626 |
| 20 | Neurofibrillary tangles (HP:0002185) | 3.67934205 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.66605481 |
| 22 | Orchitis (HP:0100796) | 3.56838121 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.54495555 |
| 24 | Periodontitis (HP:0000704) | 3.50445094 |
| 25 | Urticaria (HP:0001025) | 3.44106387 |
| 26 | Cellulitis (HP:0100658) | 3.43957704 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.43225564 |
| 28 | Optic neuritis (HP:0100653) | 3.27833825 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.27833825 |
| 30 | Metaphyseal irregularity (HP:0003025) | 3.24345701 |
| 31 | Disinhibition (HP:0000734) | 3.23975674 |
| 32 | Axonal loss (HP:0003447) | 3.23007083 |
| 33 | Prostate neoplasm (HP:0100787) | 3.18634644 |
| 34 | Glomerulonephritis (HP:0000099) | 3.18365141 |
| 35 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.10598545 |
| 36 | Agnosia (HP:0010524) | 3.10236567 |
| 37 | Meningitis (HP:0001287) | 3.09476798 |
| 38 | Increased serum ferritin (HP:0003281) | 3.07503653 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06381140 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06381140 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06381140 |
| 42 | Vasculitis (HP:0002633) | 3.03004633 |
| 43 | Dysostosis multiplex (HP:0000943) | 3.00803406 |
| 44 | Pustule (HP:0200039) | 2.96964100 |
| 45 | Amyloidosis (HP:0011034) | 2.94044121 |
| 46 | Recurrent pneumonia (HP:0006532) | 2.92577812 |
| 47 | Recurrent viral infections (HP:0004429) | 2.90857825 |
| 48 | Basal ganglia calcification (HP:0002135) | 2.88861447 |
| 49 | Nuclear cataract (HP:0100018) | 2.80470382 |
| 50 | Osteomyelitis (HP:0002754) | 2.79338153 |
| 51 | Diminished motivation (HP:0000745) | 2.68962537 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.68288561 |
| 53 | Leukocytosis (HP:0001974) | 2.65884340 |
| 54 | Neuronal loss in central nervous system (HP:0002529) | 2.65835018 |
| 55 | Thick nail (HP:0001805) | 2.65254543 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.65185003 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.63955647 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.63955647 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.62594277 |
| 60 | Apathy (HP:0000741) | 2.62358498 |
| 61 | Hepatosplenomegaly (HP:0001433) | 2.62163429 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.61583156 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.57932389 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.57932389 |
| 65 | Petechiae (HP:0000967) | 2.57479357 |
| 66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.56231238 |
| 67 | Papilledema (HP:0001085) | 2.53621191 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.49004192 |
| 69 | Retinal atrophy (HP:0001105) | 2.44112555 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42937767 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42937767 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42937767 |
| 73 | Abnormality of iron homeostasis (HP:0011031) | 2.37733501 |
| 74 | Eosinophilia (HP:0001880) | 2.37510105 |
| 75 | Inappropriate behavior (HP:0000719) | 2.37118035 |
| 76 | Recurrent lower respiratory tract infections (HP:0002783) | 2.37055825 |
| 77 | Progressive neurologic deterioration (HP:0002344) | 2.30251235 |
| 78 | Keratoconjunctivitis sicca (HP:0001097) | 2.29459926 |
| 79 | Hemoptysis (HP:0002105) | 2.26843713 |
| 80 | Sepsis (HP:0100806) | 2.25669732 |
| 81 | Malnutrition (HP:0004395) | 2.24068119 |
| 82 | Increased IgM level (HP:0003496) | 2.23146492 |
| 83 | Conjunctival telangiectasia (HP:0000524) | 2.21108623 |
| 84 | Joint hemorrhage (HP:0005261) | 2.19652394 |
| 85 | Arterial thrombosis (HP:0004420) | 2.17474216 |
| 86 | Gingival bleeding (HP:0000225) | 2.16602369 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.13886711 |
| 88 | Skin ulcer (HP:0200042) | 2.12607653 |
| 89 | Thoracic kyphosis (HP:0002942) | 2.10041833 |
| 90 | Thrombocytosis (HP:0001894) | 2.09773677 |
| 91 | Dementia (HP:0000726) | 2.08250772 |
| 92 | Personality changes (HP:0000751) | 2.08243089 |
| 93 | Polyneuropathy (HP:0001271) | 2.07523593 |
| 94 | Keratoconjunctivitis (HP:0001096) | 2.07415983 |
| 95 | Nephritis (HP:0000123) | 2.06672354 |
| 96 | Hematochezia (HP:0002573) | 2.05988075 |
| 97 | Abnormality of the periventricular white matter (HP:0002518) | 2.02847358 |
| 98 | Premature loss of primary teeth (HP:0006323) | 2.02357982 |
| 99 | Granulocytopenia (HP:0001913) | 2.02013525 |
| 100 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01285264 |
| 101 | Osteolytic defects of the hand bones (HP:0009699) | 2.01285264 |
| 102 | Epistaxis (HP:0000421) | 1.99708830 |
| 103 | Prolonged neonatal jaundice (HP:0006579) | 1.98474679 |
| 104 | Upper motor neuron abnormality (HP:0002127) | 1.98215705 |
| 105 | Asymmetric septal hypertrophy (HP:0001670) | 1.96720329 |
| 106 | Abnormality of the pleura (HP:0002103) | 1.95974943 |
| 107 | Chest pain (HP:0100749) | 1.94107441 |
| 108 | Thin bony cortex (HP:0002753) | 1.93128607 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92046245 |
| 110 | IgM deficiency (HP:0002850) | 1.91086882 |
| 111 | Complement deficiency (HP:0004431) | 1.91043254 |
| 112 | Pathologic fracture (HP:0002756) | 1.89893666 |
| 113 | Myocardial infarction (HP:0001658) | 1.89270762 |
| 114 | J-shaped sella turcica (HP:0002680) | 1.88561254 |
| 115 | Abnormality of eosinophils (HP:0001879) | 1.87190838 |
| 116 | Cheilitis (HP:0100825) | 1.86081878 |
| 117 | Tetraparesis (HP:0002273) | 1.84969205 |
| 118 | Progressive visual loss (HP:0000529) | 1.81551334 |
| 119 | Nausea (HP:0002018) | 1.81254060 |
| 120 | Global brain atrophy (HP:0002283) | 1.80905835 |
| 121 | Supranuclear gaze palsy (HP:0000605) | 1.80504717 |
| 122 | Abnormality of complement system (HP:0005339) | 1.80277654 |
| 123 | Peripheral demyelination (HP:0011096) | 1.79337434 |
| 124 | T lymphocytopenia (HP:0005403) | 1.77049991 |
| 125 | Abnormality of the lumbar spine (HP:0100712) | 1.76728057 |
| 126 | Gangrene (HP:0100758) | 1.76163243 |
| 127 | Memory impairment (HP:0002354) | 1.76133678 |
| 128 | Spondylolisthesis (HP:0003302) | 1.73417041 |
| 129 | Increased CSF protein (HP:0002922) | 1.73073318 |
| 130 | Bone pain (HP:0002653) | 1.73050434 |
| 131 | Chronic otitis media (HP:0000389) | 1.72755544 |
| 132 | Abnormality of T cell physiology (HP:0011840) | 1.72624243 |
| 133 | Gastrointestinal infarctions (HP:0005244) | 1.72508694 |
| 134 | Protuberant abdomen (HP:0001538) | 1.71778689 |
| 135 | Poor head control (HP:0002421) | 1.71180373 |
| 136 | Purpura (HP:0000979) | 1.67568635 |
| 137 | Anorexia (HP:0002039) | 1.67121732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.88877425 |
| 2 | IRAK4 | 4.74792371 |
| 3 | BLK | 4.52899263 |
| 4 | MAP3K14 | 3.36635179 |
| 5 | DDR2 | 2.97685606 |
| 6 | PBK | 2.74138182 |
| 7 | IRAK3 | 2.69997836 |
| 8 | TXK | 2.54090431 |
| 9 | TBK1 | 2.45658677 |
| 10 | TYK2 | 2.41950130 |
| 11 | MAP4K1 | 2.41013991 |
| 12 | CSK | 2.05256697 |
| 13 | KIT | 2.01090946 |
| 14 | ERN1 | 1.97072105 |
| 15 | TAOK2 | 1.94035029 |
| 16 | TESK1 | 1.83085896 |
| 17 | BTK | 1.82092537 |
| 18 | FES | 1.78625788 |
| 19 | IKBKE | 1.77012086 |
| 20 | TGFBR2 | 1.73036886 |
| 21 | FGR | 1.72419221 |
| 22 | TEC | 1.71942372 |
| 23 | PRPF4B | 1.68701175 |
| 24 | IKBKB | 1.66537275 |
| 25 | ACVR1B | 1.65721521 |
| 26 | HCK | 1.60181527 |
| 27 | NEK9 | 1.57069197 |
| 28 | CSF1R | 1.52466561 |
| 29 | SYK | 1.52180187 |
| 30 | LYN | 1.49638598 |
| 31 | TAOK1 | 1.49286327 |
| 32 | JAK3 | 1.45800250 |
| 33 | JAK1 | 1.45143186 |
| 34 | ZAP70 | 1.45118625 |
| 35 | CLK1 | 1.42866908 |
| 36 | STK10 | 1.42258579 |
| 37 | CDC42BPA | 1.41623623 |
| 38 | EPHB1 | 1.39933966 |
| 39 | GRK7 | 1.38780464 |
| 40 | TRPM7 | 1.38353408 |
| 41 | MAP2K3 | 1.34034951 |
| 42 | TESK2 | 1.18867003 |
| 43 | ERBB3 | 1.17273180 |
| 44 | STK4 | 1.12465888 |
| 45 | TAOK3 | 1.10233044 |
| 46 | MAP3K12 | 1.09714540 |
| 47 | JAK2 | 1.08453327 |
| 48 | MATK | 1.07932291 |
| 49 | RPS6KA4 | 1.06260653 |
| 50 | LCK | 1.05587774 |
| 51 | STK24 | 1.03169144 |
| 52 | EIF2AK2 | 1.02332733 |
| 53 | ITK | 1.00623344 |
| 54 | TYRO3 | 0.99213272 |
| 55 | ABL2 | 0.95742963 |
| 56 | PIM1 | 0.94922424 |
| 57 | PIM2 | 0.93162197 |
| 58 | IRAK2 | 0.91738365 |
| 59 | TGFBR1 | 0.91292687 |
| 60 | MAP3K1 | 0.89530009 |
| 61 | PRKCD | 0.89210792 |
| 62 | PAK4 | 0.84288371 |
| 63 | CAMK1G | 0.83640350 |
| 64 | ARAF | 0.81833750 |
| 65 | TTN | 0.80297852 |
| 66 | CHUK | 0.77499024 |
| 67 | RIPK1 | 0.77485002 |
| 68 | YES1 | 0.75738448 |
| 69 | BMPR2 | 0.71970888 |
| 70 | CAMKK2 | 0.69203539 |
| 71 | MARK3 | 0.68937512 |
| 72 | ABL1 | 0.64117231 |
| 73 | MAP3K13 | 0.64116009 |
| 74 | NME2 | 0.64044269 |
| 75 | DAPK2 | 0.62563372 |
| 76 | EGFR | 0.60187187 |
| 77 | ADRBK2 | 0.59760634 |
| 78 | IRAK1 | 0.59673476 |
| 79 | RPS6KA6 | 0.57768446 |
| 80 | EIF2AK3 | 0.57622797 |
| 81 | MST1R | 0.57492758 |
| 82 | PDGFRA | 0.55017957 |
| 83 | LIMK1 | 0.54086259 |
| 84 | BMX | 0.53284499 |
| 85 | MAPK4 | 0.53267487 |
| 86 | PIK3CG | 0.53172944 |
| 87 | MAP2K6 | 0.53134310 |
| 88 | GRK6 | 0.53030589 |
| 89 | MAP3K3 | 0.51923241 |
| 90 | RPS6KC1 | 0.49344086 |
| 91 | RPS6KL1 | 0.49344086 |
| 92 | BRSK2 | 0.49046141 |
| 93 | PDK2 | 0.46439828 |
| 94 | KSR2 | 0.46222948 |
| 95 | MAPKAPK2 | 0.45686435 |
| 96 | MAP3K5 | 0.45609308 |
| 97 | CDK6 | 0.44101381 |
| 98 | FYN | 0.42716454 |
| 99 | PDGFRB | 0.42264888 |
| 100 | FGFR3 | 0.41524998 |
| 101 | CAMK1D | 0.40868894 |
| 102 | SIK3 | 0.39828155 |
| 103 | PDK1 | 0.37912414 |
| 104 | PRKG2 | 0.37475939 |
| 105 | RPS6KA2 | 0.37329306 |
| 106 | SIK2 | 0.37108311 |
| 107 | KSR1 | 0.36930191 |
| 108 | LRRK2 | 0.35983970 |
| 109 | MST4 | 0.35931861 |
| 110 | MOS | 0.35037014 |
| 111 | TNK2 | 0.34959050 |
| 112 | MAP3K8 | 0.34887742 |
| 113 | PDPK1 | 0.34023402 |
| 114 | MAPK12 | 0.32529707 |
| 115 | ALK | 0.32220563 |
| 116 | MAP3K11 | 0.31375291 |
| 117 | ICK | 0.26592097 |
| 118 | IGF1R | 0.26581244 |
| 119 | NEK2 | 0.26156763 |
| 120 | LATS2 | 0.26007808 |
| 121 | EIF2AK1 | 0.25708843 |
| 122 | CDK4 | 0.25280254 |
| 123 | INSR | 0.24182683 |
| 124 | PRKCQ | 0.23900210 |
| 125 | KDR | 0.23868005 |
| 126 | CAMK4 | 0.23351263 |
| 127 | CDC7 | 0.22796306 |
| 128 | GSK3A | 0.20973508 |
| 129 | RPS6KA1 | 0.18362952 |
| 130 | CAMKK1 | 0.17531895 |
| 131 | MAPK11 | 0.17237708 |
| 132 | PTK6 | 0.17102665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.92563206 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.85141186 |
| 3 | Legionellosis_Homo sapiens_hsa05134 | 2.82308686 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.67778685 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.64981159 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.60916414 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.55908745 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.52919141 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.34943958 |
| 10 | Phagosome_Homo sapiens_hsa04145 | 2.29347210 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27834115 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 2.25546365 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.18769068 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.12922500 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.04029373 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98018558 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.97510287 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91133473 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.89112010 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81432301 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.74627377 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74387036 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.72100220 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.66040193 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64371190 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63676049 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61744055 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61459108 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.61275767 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59075276 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.52378353 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47671573 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47269713 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41010507 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39002576 |
| 36 | Bladder cancer_Homo sapiens_hsa05219 | 1.38094755 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.35180135 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.34319664 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31404214 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.30298604 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27396245 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25430879 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20450017 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18004941 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.08168707 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06713102 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96062546 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95449217 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.92046505 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91738722 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90162966 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84505657 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84126950 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82590246 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81832965 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.81003562 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79492936 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74599514 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71770664 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71606138 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.71394832 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69531142 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68457682 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63936719 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59175567 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58905419 |
| 67 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57673023 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57463270 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56903006 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55345951 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51738411 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51623522 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.50755999 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50691155 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50179153 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49622345 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.46100120 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45641446 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43032086 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40408008 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39434975 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37594002 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37523316 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37465739 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36743767 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36056542 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.35546387 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.34397136 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34077490 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30976233 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29796760 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29563988 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29164040 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26963376 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25917490 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.25497858 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25070459 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24862371 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.23413221 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.22851229 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22408739 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22395006 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21401717 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.21241415 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.20715525 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20153635 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.18108733 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15787116 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.15286637 |
| 110 | Homologous recombination_Homo sapiens_hsa03440 | 0.14320574 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.14306654 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13745638 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13324070 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.12357736 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.11885393 |

